Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01744041 · ClinicalTrials.gov registry record · NA

Mommy-Baby Treatment for Perinatal Depression

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT01744041 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 42 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01744041, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

Perinatal depression is a major public health problem, affecting 15% of women during pregnancy through the postpartum period, with adverse consequences for the mother, the fetus, the infant, and the family. Despite increasing evidence of the importance of this critical risk interval, little research has investigated the effects of depression treatment during pregnancy on infant outcomes. The purpose of this study is to test the feasibility, acceptability, and effectiveness of a new intervention, Interpersonal psychotherapy for the mother-infant dyad (IPT-Dyad). This intervention begins during pregnancy and continues with the mother and infant until one year postpartum. The investigators hypothesize that IPT-Dyad will be better than treatment as usual in reducing depressive symptoms, improving psychosocial functioning,increasing parenting self-efficacy, improving infant emotional development, and enhancing mother-infant relationship quality.

Interventions

  • OTHER Enhanced Treatment as Usual
  • BEHAVIORAL Dyadic Interpersonal Psychotherapy

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2012-11
Est. Completion 2017-01-31
Phase NA

What the Registry Record Tells You About NCT01744041

The ClinicalTrials.gov registry entry for NCT01744041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Enhanced Treatment as Usual is the first listed.

NCT01744041 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01744041 about?

NCT01744041 is a clinical study titled "Mommy-Baby Treatment for Perinatal Depression". Perinatal depression is a major public health problem, affecting 15% of women during pregnancy through the postpartum period, with adverse consequences for the mother, the fetus, the infant, and the family. Despite increasing evidence of the importance of this critical risk interval, little research...

What is the current status of trial NCT01744041?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2012-11. Estimated completion is 2017-01-31.

What interventions are being tested in trial NCT01744041?

The interventions under investigation include: Enhanced Treatment as Usual (OTHER), Dyadic Interpersonal Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01744041?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.